Skip to content
NP FADY

Turn One Knob, Then Wait: A Safer Autism Medication Plan

One change at a time, then wait. How to tell when a new psychiatric label deserves a second look, how to thin a pile of medicines safely, which warnings apply across the lifespan, and which changes need same-day care.

Originally published September 16, 2026

Last reviewed September 16, 2026

Clinical review: Fady Boules, PMHNP-BC

14 min read

Picture an old shower. The water takes a while to change. If you turn both knobs at once, and keep turning because nothing seems to happen, you end up too hot or too cold. The fix is simple. Turn one knob a little. Wait. Then decide.

A medication plan for an autistic person works best the same way. This guide is for parents, caregivers, and autistic adults. It covers what medicine can and cannot do, where the research is strong or thin, and how to tell when a new label may not fit.

Key takeaways

  • No medicine treats autism itself. Medicine can treat a condition that travels with autism, such as ADHD, anxiety, depression, or a sleep problem. It can also target one clear problem, such as dangerous aggression.
  • The best medication research in autistic people covers three areas: ADHD in children, severe irritability in children, and sleep. Most other advice is borrowed from studies of people who are not autistic.
  • Some new labels need a second look. A loved routine is not automatically OCD. Big feelings are not automatically bipolar disorder.
  • A safer plan names one target, changes one thing at a time, sets a review date, and says when to stop.
  • Looking sleepy or “quieter” is not the same as getting better.
  • A sudden loss of speech or movement, talk of suicide, or days of little sleep with unusual energy need same-day care.

Other conditions are common, not a given

Autism does not protect anyone from other health conditions. A 2019 review of 96 studies found that ADHD and anxiety were the most common diagnoses alongside autism. Sleep-wake disorders and depression were also common. 1 The numbers varied a lot between studies. They show what is common. They cannot predict what will happen to one person. Our essay on missed conditions in autism walks through those numbers.

Adults are affected too. A 2019 review found that about 27 in 100 autistic adults had a current anxiety disorder, and about 23 in 100 had current depression. Across a whole lifetime, those figures rose to about 42 and 37 in 100. 2

What medicine can and cannot do

England’s national health guidance (NICE) says not to use antipsychotics, antidepressants, or anticonvulsants to treat the core features of autism in children and young people. 3 Core features are the social communication differences, repetitive behaviors, and focused interests that make up autism. They are part of a person. They are not a target for pills.

Medicine has a different job. It can treat a separate condition that causes distress or harm. It can also aim at one specific, measurable problem.

Where the evidence is strong, thin, or borrowed

AreaEvidence and what it means
ADHD in childrenWhat studies in autistic people show: Methylphenidate, atomoxetine, and guanfacine extended-release helped in trials. In a major methylphenidate study, about half of the children responded, and 18 in 100 stopped because of side effects. 4 5 6
What it means for you: Worth a careful trial when ADHD is confirmed. Expect smaller steps and closer follow-up.
Severe irritability in childrenWhat studies in autistic people show: Risperidone and aripiprazole are FDA-approved for irritability linked to autism. In the main risperidone trial, 69 in 100 children responded, compared with 12 in 100 on placebo. 7 8 9 A 2025 review rated this evidence low certainty and short term. 10
What it means for you: Real help for serious problems, with real risks: weight gain, blood sugar and cholesterol changes, sleepiness, and movement side effects. 8 9
SleepWhat studies in autistic people show: Routine and behavior changes come first. In pooled studies, melatonin helped children fall asleep about half an hour sooner. 11
What it means for you: Start with the sleep routine. Ask before adding any sleep medicine.
AnxietyWhat studies in autistic people show: Cognitive behavioral therapy (CBT) adapted for autism has the strongest research support. 12 A 2026 review of seven SSRI trials in autistic children found no clear benefit for the outcomes measured and slightly more side effects. 13
What it means for you: Adapted therapy first. An SSRI can still be reasonable for a confirmed anxiety disorder, based on wider research.
Depression, OCD, PTSD, bipolar disorder, psychosisWhat studies in autistic people show: Few or no medication trials in autistic people who have these diagnoses. 14
What it means for you: Care follows the standard guidance for each condition, with extra care in how medicine is started and checked.

Two warnings about this table. First, many SSRI trials in autism tested repetitive behaviors, not a diagnosed anxiety disorder or depression. 15 No study in the 2026 review measured depression at all. 13 So those results do not prove that SSRIs fail for a carefully diagnosed condition. Second, one U.S. autism center has proposed its own first choices for anxiety and depression. That proposal is expert opinion, not the result of trials that compared medicines head to head. 16

It also matters who gets studied. A review of autism research found that 94 in 100 participants (in studies that reported intellectual ability) did not have an intellectual disability. Only about 2 in 100 were minimally speaking. 17 If your loved one has high support needs, the studies may not look much like them.

For more on each area, see autism and ADHD together, anxiety and adapted CBT, sleep in autism, and aggression and self-injury.

When a new label needs a second look

Autistic traits can tick boxes on a checklist for another condition. A new diagnosis should explain something that changed, not something that was always there. The most useful question is simple. What changed from this person’s usual self, when did it start, and where does it show up?

LabelHow to tell them apart
OCDCan be confused with: Loved routines, scripts, deep interests
What points toward the new diagnosis: Unwanted, frightening thoughts, and rituals done to stop a feared outcome
Bipolar disorderCan be confused with: ADHD, lifelong big feelings, poor sleep, hyperfocus
What points toward the new diagnosis: A clear episode unlike the usual self, such as days of needing little sleep while full of energy
PsychosisCan be confused with: Literal thinking, talking to oneself, scripting, rich imagination
What points toward the new diagnosis: New fixed false beliefs, voices heard as coming from outside, or a drop in daily function
Tic disorderCan be confused with: Stimming, often rhythmic and calming
What points toward the new diagnosis: Sudden, non-rhythmic movements or sounds, often with an urge just before
DepressionCan be confused with: Autistic burnout, shutdown, grief, poor sleep
What points toward the new diagnosis: Lasting loss of joy, even in favorite interests, with hopelessness or changes in sleep and appetite
Personality disorderCan be confused with: Autism, masking, trauma
What points toward the new diagnosis: A long pattern that still makes sense after autism and trauma are fully considered

Autistic burnout is described as long-lasting exhaustion, loss of function, and lower tolerance for sensory input. In interviews, autistic adults described it as different from depression. 18 The two can be hard to tell apart, so a clinician should check for both. Our essay on autistic burnout and depression goes deeper.

Wrong labels happen. In a Dutch study of 1,211 autistic adults, about 1 in 4 said they had once received a psychiatric diagnosis they now saw as a misdiagnosis. Personality disorders topped the list. Women reported this more often than men. 19

Five steps for trying a medicine safely. The 3-to-4-week review and 6-week stop rule are NICE advice for antipsychotics used for behavior in young people. Tap the image to read it full size.

Five parts of a safer plan

  1. Name one target. “Calmer” is vague. “Fewer hits at school” or “asleep within 30 minutes” can be counted. Write down how often it happens now, before anything changes.
  2. Check the body first. In autistic children, stomach problems are linked with more irritability, and poor sleep is linked with more irritability and aggression. 20 21 Pain, dental problems, seizures, and side effects of other medicines can also show up as behavior.
  3. Turn one knob, then wait. Change one medicine or one dose at a time. England’s ADHD guidance offers autistic people the same medicine choices as everyone else, with slower dose increases and more frequent check-ins. 22 A low start should still move toward a dose that can work.
  4. Count side effects as part of the result. Sleepiness, a flat mood, or less spontaneity is a side effect, not success. Track sleep, appetite, weight, mood, and new restlessness.
  5. Set a review date and a stop rule on day one. For antipsychotics used for behavior in young people, NICE guidance says to review after 3 to 4 weeks and stop if there is no clear, important benefit by 6 weeks. 3

When the medicine list grows

Over the years, medicines can pile up. Each one made sense when it started. Together they can add sleepiness, weight gain, constipation, or falls.

  • Bring every medicine to each visit. Include as-needed pills, vitamins, supplements, and melatonin.
  • Ask what each one is for and whether it still helps.
  • Stop medicines one at a time, with your prescriber, usually by lowering the dose slowly.
  • Know that stopping can cause its own symptoms. Stopping guanfacine extended-release suddenly can cause a sharp rise in blood pressure, so the label calls for a slow taper. 23 Benzodiazepines can cause serious withdrawal reactions when stopped too fast. 24 Withdrawal can look like the old problem coming back.

Across the lifespan

  • Children, teens, and young adults. Antidepressants carry an FDA boxed warning. They increased suicidal thoughts and behaviors in young people in short-term studies. 25 Two non-stimulant ADHD medicines, atomoxetine and viloxazine, carry similar warnings. 26 27 Watch closely after a new start or a dose change.
  • Adults. Most treatment advice is borrowed from studies of adults who are not autistic. An adult’s own report of side effects is key data.
  • Pregnancy. Valproate carries an FDA boxed warning for birth defects and lower IQ in exposed children. 28 Anyone who could become pregnant should talk about this before starting it. Do not stop a medicine suddenly without talking to your prescriber.
  • Older adults. Antipsychotics carry an FDA boxed warning for a higher risk of death in older adults with dementia-related psychosis. 8 Falls, confusion, and drug interactions need extra attention.
  • Minimal speech or intellectual disability. Less self-report does not mean less distress. A change in behavior may be the first sign of pain, fear, depression, or a side effect.

Get help the same day if you see

  • A new loss of speech, freezing in odd positions, or a sharp drop in movement or self-care. These can be signs of catatonia, a treatable emergency. Antipsychotics need great caution here because they can raise the risk of a dangerous reaction. 29 Read more about catatonia in autism.
  • Days of little sleep with unusual energy, risk-taking, or racing speech, especially after starting an antidepressant. Antidepressant labels warn that they can trigger mania in people with bipolar disorder. 25
  • Talk of suicide, a plan, or giving belongings away. In studies of autistic people without intellectual disability, about 34 in 100 reported suicidal thoughts, and about 24 in 100 reported a suicide attempt or suicidal behavior. 30 Ask directly, in plain words. Research suggests that asking about suicide does not put the idea in someone’s head. 31 The crisis resources below list where to reach help right now.
  • High fever with stiff muscles and confusion while taking an antipsychotic. This can be neuroleptic malignant syndrome, a medical emergency. 8

Questions to bring to the next visit

  • What exact problem is this medicine for?
  • Does the evidence come from autistic people, or is it borrowed?
  • Which side effects should we watch, and which ones mean we call right away?
  • When will we decide whether it is working?
  • If it does not help, how will we stop it?

Frequently asked questions

Can medication make my child less autistic?

No. Medicine is not used to change the core features of autism. 3 It can treat a separate condition, like ADHD or anxiety, or one clear target, like dangerous aggression.

Why did the prescriber start with such a small dose?

Autistic children with ADHD had more side effects than is typical in ADHD studies of non-autistic children. 4 Guidance advises slower increases and closer follow-up. 22 A small start is fine. It should still move toward a dose that can help, if side effects allow.

SSRIs did not help in autism studies. Should we avoid them?

Not always. Many of those studies tested repetitive behaviors, not a diagnosed anxiety disorder, OCD, or depression. 13 15 For a confirmed condition, an SSRI may still be reasonable. Talk through the benefits and risks with your prescriber.

My child gained a lot of weight on an antipsychotic. What can we do?

Tell the prescriber early. Options include rechecking whether the medicine is still needed, lowering the dose, or switching. In a 16-week trial in autistic young people, metformin led to a modest drop in body mass index compared with placebo. It caused more stomach side effects. 32

Is it a problem to be on the same medicines for years?

Not always. Long-term use makes sense when there is clear, ongoing benefit. Ask for a review at least once a year. Check whether each medicine still has a job to do.

References

1. Lai MC, Kassee C, Besney R, et al. Prevalence of co-occurring mental health diagnoses in the autism population: a systematic review and meta-analysis. Lancet Psychiatry. 2019;6(10):819-829. doi:10.1016/S2215-0366(19)30289-5

2. Hollocks MJ, Lerh JW, Magiati I, Meiser-Stedman R, Brugha TS. Anxiety and depression in adults with autism spectrum disorder: a systematic review and meta-analysis. Psychol Med. 2019;49(4):559-572. doi:10.1017/S0033291718002283

3. National Institute for Health and Care Excellence. Autism spectrum disorder in under 19s: support and management (CG170), recommendations 1.3.2 and 1.4.10. nice.org.uk/guidance/cg170

4. Research Units on Pediatric Psychopharmacology Autism Network. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry. 2005;62(11):1266-1274. doi:10.1001/archpsyc.62.11.1266

5. Scahill L, McCracken JT, King BH, et al. Extended-release guanfacine for hyperactivity in children with autism spectrum disorder. Am J Psychiatry. 2015;172(12):1197-1206. doi:10.1176/appi.ajp.2015.15010055

6. Rodrigues R, Lai MC, Beswick A, et al. Practitioner review: pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis. J Child Psychol Psychiatry. 2021;62(6):680-700. doi:10.1111/jcpp.13305

7. McCracken JT, McGough J, Shah B, et al. Risperidone in children with autism and serious behavioral problems. N Engl J Med. 2002;347(5):314-321. doi:10.1056/NEJMoa013171

8. DailyMed. RISPERDAL (risperidone) prescribing information. Revised May 2026. dailymed.nlm.nih.gov

9. DailyMed. ABILIFY (aripiprazole) prescribing information. Revised January 2025. dailymed.nlm.nih.gov

10. Meza N, Franco JVA, Sguassero Y, et al. Atypical antipsychotics for autism spectrum disorder: a network meta-analysis. Cochrane Database Syst Rev. 2025;5:CD014965. doi:10.1002/14651858.CD014965.pub2

11. Williams Buckley A, Hirtz D, Oskoui M, et al. Practice guideline: treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder. Neurology. 2020;94(9):392-404. doi:10.1212/WNL.0000000000009033

12. Sharma S, Hucker A, Matthews T, Grohmann D, Laws KR. Cognitive behavioural therapy for anxiety in children and young people on the autism spectrum: a systematic review and meta-analysis. BMC Psychol. 2021;9:151. doi:10.1186/s40359-021-00658-8

13. Trinari E, Noronha NJ, Papola D, et al. Selective serotonin reuptake inhibitors for children with autism spectrum disorder: a systematic review and meta-analysis. Clin Med Insights Pediatr. 2026;20:11795565261442820. doi:10.1177/11795565261442820

14. Menezes M, Harkins C, Robinson MF, Mazurek MO. Treatment of depression in individuals with autism spectrum disorder: a systematic review. Res Autism Spectr Disord. 2020;78:101639. doi:10.1016/j.rasd.2020.101639

15. Deb S, Roy M, Lee R, et al. Randomised controlled trials of antidepressant and anti-anxiety medications for people with autism spectrum disorder: systematic review and meta-analysis. BJPsych Open. 2021;7(6):e179. doi:10.1192/bjo.2021.1003

16. Manter MA, Birtwell KB, Bath J, et al. Pharmacological treatment in autism: a proposal for guidelines on common co-occurring psychiatric symptoms. BMC Med. 2025;23:11. doi:10.1186/s12916-024-03814-0

17. Russell G, Mandy W, Elliott D, White R, Pittwood T, Ford T. Selection bias on intellectual ability in autism research: a cross-sectional review and meta-analysis. Mol Autism. 2019;10:9. doi:10.1186/s13229-019-0260-x

18. Raymaker DM, Teo AR, Steckler NA, et al. “Having all of your internal resources exhausted beyond measure and being left with no clean-up crew”: defining autistic burnout. Autism Adulthood. 2020;2(2):132-143. doi:10.1089/aut.2019.0079

19. Kentrou V, Livingston LA, Grove R, Hoekstra RA, Begeer S. Perceived misdiagnosis of psychiatric conditions in autistic adults. EClinicalMedicine. 2024;71:102586. doi:10.1016/j.eclinm.2024.102586

20. Chaidez V, Hansen RL, Hertz-Picciotto I. Gastrointestinal problems in children with autism, developmental delays or typical development. J Autism Dev Disord. 2014;44(5):1117-1127. doi:10.1007/s10803-013-1973-x

21. Mazurek MO, Sohl K. Sleep and behavioral problems in children with autism spectrum disorder. J Autism Dev Disord. 2016;46(6):1906-1915. doi:10.1007/s10803-016-2723-7

22. National Institute for Health and Care Excellence. Attention deficit hyperactivity disorder: diagnosis and management (NG87), recommendations 1.7.18 and 1.7.28. nice.org.uk/guidance/ng87

23. DailyMed. INTUNIV (guanfacine extended-release) prescribing information, sections 2.5 and 5.4. Revised June 2025. dailymed.nlm.nih.gov

24. U.S. Food and Drug Administration. FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class. September 23, 2020. fda.gov

25. DailyMed. LEXAPRO (escitalopram) prescribing information, boxed warning and section 5.5. Revised October 2023. dailymed.nlm.nih.gov

26. DailyMed. STRATTERA (atomoxetine) prescribing information. Revised December 2025. dailymed.nlm.nih.gov

27. DailyMed. QELBREE (viloxazine extended-release) prescribing information. Revised January 2025. dailymed.nlm.nih.gov

28. U.S. Food and Drug Administration. DEPAKOTE (divalproex sodium) prescribing information, boxed warning. Revised May 2025. accessdata.fda.gov

29. Rogers JP, et al. Evidence-based consensus guidelines for the management of catatonia: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2023;37(4):327-369. doi:10.1177/02698811231158232

30. Newell V, Phillips L, Jones C, Townsend E, Richards C, Cassidy S. A systematic review and meta-analysis of suicidality in autistic and possibly autistic people without co-occurring intellectual disability. Mol Autism. 2023;14:12. doi:10.1186/s13229-023-00544-7

31. Dazzi T, Gribble R, Wessely S, Fear NT. Does asking about suicide and related behaviours induce suicidal ideation? What is the evidence? Psychol Med. 2014;44(16):3361-3363. doi:10.1017/S0033291714001299

32. Anagnostou E, Aman MG, Handen BL, et al. Metformin for treatment of overweight induced by atypical antipsychotic medication in young people with autism spectrum disorder: a randomized clinical trial. JAMA Psychiatry. 2016;73(9):928-937. doi:10.1001/jamapsychiatry.2016.1232

This article is for education. It does not diagnose a condition, replace individual care, or promise services. Do not start, stop, or change any medicine without your prescribing clinician. Reading this does not create a clinician-patient relationship. Evidence checked September 16, 2026.

If you or someone you know is in crisis

  • Call 911 or go to your nearest emergency room for any life-threatening emergency.
  • 988 Suicide & Crisis Lifeline — call or text 988, or chat at 988lifeline.org, available 24/7, free and confidential. En español: marque 988 y oprima 2, o envíe AYUDA al 988. Deaf or hard of hearing: 988 videophone (ASL) or TTY 711 then 988. Veterans: 988 and press 1, or text 838255.
  • Crisis Text Line — text HOME to 741741.
  • The Trevor Project (crisis support for LGBTQ+ young people) — call 1-866-488-7386, or text START to 678-678.
  • National Sexual Assault Hotline (RAINN) — call 1-800-656-HOPE (4673) or text HOPE to 64673; free, confidential, 24/7. Online chat at RAINN.org/hotline.
  • National Domestic Violence Hotline — call 1-800-799-SAFE (7233) or text START to 88788; 24/7, help in 200+ languages. Online chat at TheHotline.org. If your phone or computer may be monitored, calling from a safer device is an option.
  • Riverside County — Inland SoCal Crisis Helpline 951-686-HELP (4357), 24/7 (Inland SoCal United Way / 211+, in partnership with RUHS-BH); Community Access, Referral, Evaluation and Support (CARES) Line 800-499-3008, 24/7.
  • San Bernardino County — Access Unit (Behavioral Health Helpline) 888-743-1478, 24/7; Mobile Crisis/CCRT 800-398-0018 (24/7, all ages) or text 909-420-0560. Arrowhead Regional Medical Center (ARMC) has a dedicated walk-in adolescent psychiatric ER (ages 13–17).
  • Children under 13 — call 911 for immediate danger, contact your county's mobile crisis team (they respond to all ages), or go to the nearest pediatric emergency room.
  • California Peer-Run Warm Line (non-crisis — someone to talk to) — call or text 1-855-600-WARM (9276); daytime and evening hours, not a 24/7 line.
  • NP Fady (non-emergency) — for routine scheduling or questions, call (909) 707-6261. This line is not monitored for emergencies.
Fady Boules, PMHNP-BC

Written and clinically reviewed by Fady Boules, PMHNP-BC

Board-certified psychiatric mental health nurse practitioner. In person in Redlands and by telepsychiatry across California, through Inland Psychiatric Medical Group.

About Fady NPI registry How care works Last reviewed September 16, 2026

Keep reading

Go deeper, at your own pace

More from the library, on the same topic.

Autism Medication: A Parent's Map of the Evidence

Read the essay

When It Isn't Autism: Other Differences That Still Need Support

Read the essay

Sleep in Autism: What to Try, What to Check

Read the essay

Or browse the full essay library.